JAAD onlineSystemic involvement in TREX1-associated familial chilblain lupus
References (5)
- et al.
Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus
Am J Med Genet A
(2011) Nucleic acid metabolism and systemic autoimmunity revisited
Arthritis Rheum
(2010)
Cited by (37)
TREX1 plays multiple roles in human diseases
2022, Cellular ImmunologyCitation Excerpt :An intriguing phenomenon is that the same pathogenic variant of TREX1, even in the same family, exhibits diverse penetrance. Taking the most common pathogenic variant found in patients with FCL, TREX1 D18N, as an example, some patients with this pathogenic variant suffered from both AGS and FCL [14,15], while others had only FCL [11–13,16,81]. These cases raised concerns that the epigenetic regulation of TREX1 expression and/or other TREX1-independent factors (such as environmental changes) should also be included in future studies on TREX1-associated inflammatory disease development.
Skin biopsies: their utility to allergists and immunologists
2022, Allergic and Immunologic Diseases: A Practical Guide to the Evaluation, Diagnosis and Management of Allergic and Immunologic DiseasesSTING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation
2020, iScienceCitation Excerpt :Stimulator of interferon genes (STING), also known as transmembrane protein 173 (TMEM173), is a cytoplasmic adaptor protein that acts downstream of cGAS to enhance IFN-I production (Ishikawa et al., 2009). The loss-of-function mutations in a DNA-specific exonuclease gene TREX1, resulting in increased cytosolic DNA levels, are observed in the type I interferonopathies Aicardi-Goutieres syndrome (AGS) and chilblain lupus (Crow et al., 2006; Günther et al., 2013). Consistent with these scenarios in human, Trex1-deficient mice exhibit fatal inflammation and autoimmunity (Morita et al., 2004; Stetson et al., 2008).
Comparison of RT-qPCR and Nanostring in the measurement of blood interferon response for the diagnosis of type I interferonopathies
2019, CytokineCitation Excerpt :More recently, a group of mendelian disorders due to mutations in genes involved in nucleic acid metabolism or PRR causing an excessive secretion of type I IFN has been classified as type I interferonopathies. Aicardi-Goutières syndrome (AGS) [15], STING-associated vasculopathy with onset in infancy (SAVI) [16], familial chilblain lupus [17], spondyloenchondrodysplasia (SPENCD) [18], proteasome-associated auto-inflammatory syndrome (PRAAS) [19] and Singleton-Merten syndrome (SMS) [20,21] are the main genetic type I interferonopathies described. Tetrasomy 9p is a very rare genetic disorder arising from a duplication of the short arm of the chromosome 9.
Familial chilblain lupus: Four cases spanning three generations
2018, Annales de Dermatologie et de VenereologieAutoinflammatory Diseases in Pediatric Dermatology–Part 2: Histiocytic, Macrophage Activation, and Vasculitis Syndromes
2017, Actas Dermo-Sifiliograficas
Supported by grants from the Deutsche Forschungsgemeinschaft (GU1212/1-1 to PD Dr Günther and LE 1074/4-1 to Prof Dr Lee-Kirsch) and a MeDDrive grant 60322 from the Medical Faculty, Technical University Dresden (PD Dr Günther).
Conflicts of interest: None declared.